Artificial Intelligence in Drug Discovery Market by Process (Target, Lead), Use Case (Design & Optimisation: Vaccine, Antibody; Disease understanding, PK/PD), Therapy (Cancer, CNS, CVS), Tool (ML:DL (CNN, GAN)), End User & Region - Global Forecast to 2029

Artificial Intelligence in Drug Discovery Market by Process (Target, Lead), Use Case (Design & Optimisation: Vaccine, Antibody; Disease understanding, PK/PD), Therapy (Cancer, CNS, CVS), Tool (ML:DL (CNN, GAN)), End User & Region - Global Forecast to 2029

The global artificial intelligence (AI) in drug discovery market is projected to reach 6.89 billion by 2029 from 1.86 billion in 2024, at a CAGR of 29.9% from 2024 to 2029. Increasing cross-industry collaborations and partnerships drive the growth of the artificial intelligence (AI) in drug discovery market by combining expertise, resources, and technology from various aspects of the drug discovery supply chain. For instance, in March 2024, Cognizant collaborated with NVIDIA to use generative AI through the BioNeMo platform, with the goal of transforming drug discovery and accelerating the development of life-saving therapies. Similarly, in August 2024, Exscientia Recursion and Exscientia plc announced a agreement, combining their technologies to enhance drug discovery. The integrated Recursion OS will enhance drug discovery through patient-centric target discovery, AI-driven design, quantum mechanics modeling, automated chemical synthesis, and other features. The combined company plans to complete 10 clinical trials within 18 months. Exscientia shareholders will receive Recursion stock, with Recursion shareholders owning 74% of the combined company. The deal is worth USD 850M in cash and is expected to close by early 2025.

“Oncology held the largest market share in the artificial intelligence (AI) in drug discovery market, by therapeutic area in 2023.”

Based on therapeutic areas, the artificial intelligence (AI) in drug discovery market is segmented into oncology, infectious diseases, neurology, metabolic diseases, cardiovascular diseases, immunology, mental health, and others (respiratory diseases, nephrology, dermatological diseases, genetic disorders, inflammatory diseases, and gastrointestinal). The oncology segment held the largest market share in the artificial intelligence (AI) in drug discovery market due to high prevalence of cancer and the complex nature of tumor biology, which necessitates innovative approaches for drug development. There were approximately 20 million new cancer cases and 9.7 million cancer-related deaths worldwide in 2022. Similarly, in 2024, 2.0 million new cancer cases and 611,720 cancer deaths are projected to occur in the US. The growing availability of biomedical data from cancer research, patient records, genomic studies, multi-omics datasets (genomics, proteomics, transcriptomics), and clinical trials provides an opportunity to leverage AI for pattern recognition and predicting drug interactions. The high demand for personalized medicine and targeted therapies in oncology, large commercial returns, emerging focus on immuno-oncology (especially checkpoint inhibitors and T-cell therapies), and exhaustive data availability drive investment in Al-driven solutions, elevating it to the forefront of the drug discovery landscape.

“Understanding disease use case to witness the fastest growth during the forecast period.”

Based on the use case, artificial intelligence (AI) in drug discovery market is segmented into understanding the disease, drug repurposing, de novo drug design, drug optimization, and safety & toxicity. The understanding disease is poised to be the fastest-growing use case over the forecast period. AI’s capacity to assess complex biological data and identify disease mechanisms is critical in early-stage drug development. AI helps researchers better understand disease pathways, genetic factors, and biomarkers, all of which are necessary for developing targeted therapies. Understanding diseases is required to identify potential drug targets, which enhances the efficiency of subsequent stages such as drug design and testing. The growth use of AI for phenotypic screening, image analysis, detecting anomalies in genetic perturbations on cellular or tissue morphology, biomarker identification, (-omics) data mining is expected to fuel the market growth.

“North America to dominate the market over the forecast period.”

Based on the region, the artificial intelligence (AI) in drug discovery market is segmented into five major regional segments: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American region dominated the artificial intelligence (AI) in drug discovery market in 2023. Several factors contribute to this dominance, including significant investment in healthcare technology, strong cross-sector collaborations, the presence of large pharmaceutical and biotechnology companies, and a favorable regulatory environment. The total investments in AI in Drug Development companies are USD 60.2 billion as of March 2023. A large wave of proof-of-concept studies and substantial advances in democratizing AI technology are also propelling the growth of the market. For example, in January 2023, AbSci created and validated de novo antibodies in silico with generative Al. Furthermore, in February 2023, the FDA granted an Orphan Drug Designation to a drug discovered and designed with Al. Insilico Medicine and began a global Phase I trial for the drug.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace.

Breakdown of supply-side primary interviews by company type, designation, and region:

By Company Type: Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%)

By Designation – Demand Side: Purchase Managers (45%), Heads of Artificial Intelligence, Machine Learning, Drug Discovery, and Computational Molecular Design (30%), and Research Scientists (25%)

By Designation – Supply Side: C-level Excecutives & Director level (35%), Managers (40%), and Others (25%)

By Region: North America (45%), Europe (30%), Asia Pacific (20%), and Rest of the world (5%)

List of Companies Profiled in the Report

NVIDIA Corporation (US)

Exscientia (UK)

Google (US)

BenevolentAI (UK)

Recursion (US)

Insilico Medicine (US)

Schrödinger, Inc. (US)

Microsoft (US)

Atomwise Inc. (US)

Illumina, Inc. (US)

Numedii, Inc. (US)

Xtalpi Inc. (US)

Iktos (France)

Tempus (US)

DEEP GENOMICS (Canada)

Verge Genomics (US)

BenchSci (Canada)

Insitro (US)

Valo Health (US)

BPGBio, Inc. (US)

Merck KGaA (Germany)

IQVIA (US)

Tencent Holdings Limited (China)

Predictive Oncology, Inc. (US)

CytoReason (Israel)

Owkin, Inc. (US)

Cloud Pharmaceuticals (US)

Evaxion Biotech (Denmark)

Standigm (South Korea)

BIOAGE (US)

Envisagenics (US)

Abcellera (US)

Centella (India)

The study includes an in-depth competitive analysis of these key players in the artificial intelligence (AI) in drug discovery market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the artificial intelligence (AI) in drug discovery market by process (target identification & selection, target validation, hit identification & prioritization, hit-to-lead identification/lead generation, lead optimization, and candidate selection & validation), by use case (understanding disease, drug repurposing, de novo drug design [small molecule design, vaccines design, antibody & other biologics design], drug optimization [small molecule optimization, vaccines optimization, antibody & other biologics optimization], and safety and toxicity), by therapeutic area (oncology, infectious diseases, neurology, metabolic diseases, cardiovascular diseases, immunology, mental health, others), by player type (end-to-end solution providers, niche/point solutions providers, AI technology providers, business process service providers), by tools (machine learning, natural language processing, context-aware process and computing, computer vision, image analysis (including optical character recognition)), by deployment (on-premise, cloud-based, SaaS-based), by end user (pharmaceutical & biotechnology companies, contract research organizations (CROs), and research centers, academic institutes, & government organizations) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the artificial intelligence (AI) in drug discovery market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services, key strategies such as product launches and enhancements, investments, partnerships, collaborations, agreements, joint ventures, funding, acquisitions, expansions, conferences, FDA clearances, sales contracts, alliances, and other recent developments associated with the artificial intelligence (AI) in drug discovery market. Competitive analysis of upcoming startups in the artificial intelligence (AI) in drug discovery market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the artificial intelligence (AI) in drug discovery market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (growing cross-industry collaborations and partnerships, growing need to reduce time and cost of drug discovery and development, patent expiry of several drugs, AI application in oncology areas, integration of multi-omics data, initiatives for research on rare diseases and orphan drugs), restraints (shortage of AI workforce and ambiguous regulatory guidelines for medical software, interpretability of AI), opportunities (growing biotechnology industry, increasing focus on emerging markets, focus on developing human-aware AI systems, increasing use of AI in single cell analysis, rapid expansion of biomarker, disease types, and subtypes identification, growing demand for precision and personalized medicine), and challenges (limited availability of data sets, lack of required tools and usability, computational limitations of advanced AI models, challenges regarding the accessibility of high-quality data) influencing the growth of the artificial intelligence (AI) in drug discovery market

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the artificial intelligence (AI) in drug discovery market

Market Development: Comprehensive information about lucrative markets – the report analyses the artificial intelligence (AI) in drug discovery market across varied regions.

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the artificial intelligence (AI) in drug discovery market

Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as NVIDIA Corporation (US), Exscientia (UK), Google (US), BenevolentAI (UK), Recursion (US), Insilico Medicine (US), Schrödinger, Inc. (US), Microsoft (US), Atomwise Inc. (US), Illumina, Inc. (US), Numedii, Inc. (US), Xtalpi Inc. (US), Iktos (France), Valo Health (US), and Merck KGaA (Germany), among others in artificial intelligence (AI) in drug discovery market.

Tables List

Table 1 Artificial Intelligence In Drug Discovery Market:

Inclusions And Exclusions

Table 2 Exchange Rates Utilized For Conversion To Usd, 2021–2023

Table 3 Artificial Intelligence In Drug Discovery Market: Factor Analysis

Table 4 Artificial Intelligence In Drug Discovery Market: Market Sizing Assumptions

Table 5 Artificial Intelligence In Drug Discovery Market: Risk Assessment

Table 6 Artificial Intelligence In Drug Discovery Market: Impact Analysis

Table 7 Indicative List Of Collaborations And Partnerships, 2021–2023

Table 8 Indicative List Of Drugs Losing Patents In 2023 And 2024

Table 9 Artificial Intelligence In Drug Discovery Market: Role In Ecosystem

Table 10 North America: Regulatory Bodies, Government Agencies, And Other Organizations

Table 11 Europe: Regulatory Bodies, Government Agencies, And Other Organizations

Table 12 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations

Table 13 Latin America: Regulatory Bodies, Government Agencies, And Other Organizations

Table 14 Middle East & Africa: Regulatory Bodies, Government Agencies, And Other Organizations

Table 15 North America: Regulatory Framework

Table 16 Europe: Regulatory Framework

Table 17 Asia Pacific: Regulatory Framework

Table 18 Middle East & Africa: Regulatory Framework

Table 19 Latin America: Regulatory Framework

Table 20 Artificial Intelligence In Drug Discovery Market: Indicative Selling Price, By Region, 2021–2023

Table 21 Artificial Intelligence In Drug Discovery Market: Indicative Pricing,

By Process, 2023

Table 22 Artificial Intelligence In Drug Discovery Market: Porter’s Five Forces Analysis

Table 23 Influence Of Stakeholders On Buying Process Of Top

Three End Users (%)

Table 24 Key Buying Criteria For Top Three End Users

Table 25 Jurisdiction Analysis Of Top Applicant Countries For Artificial Intelligence In Drug Discovery

Table 26 Artificial Intelligence In Drug Discovery Market: List Of Patents/Patent Applications

Table 27 Artificial Intelligence In Drug Discovery Market: Key Conferences & Events, January 2024–december 2025

Table 28 Case Study 1: Leveraging Ai-driven Precision Medicine To Identify Patient Subtypes And Novel Targets In Inflammatory Bowel Disease

Table 29 Case Study 2: Artificial Intelligence-driven Drug Discovery

And Co-development

Table 30 Case Study 3: Advancing Gene Therapy For Rare Neurological Diseases

Table 31 Case Study 4: Artificial Intelligence Design And Optimization Of Exs4318

Table 32 Case Study 5: Artificial Intelligence-driven Design And Clinical Evaluation Of Gtaexs617

Table 33 Key Artificial Intelligence-derived Clinical Assets, By Company

Table 34 Artificial Intelligence In Drug Discovery Market, By Process,

2022–2029 (Usd Million)

Table 35 Artificial Intelligence In Drug Discovery Market For Target Identification & Selection, By Region, 2022–2029 (Usd Million)

Table 36 Artificial Intelligence In Drug Discovery Market For Target Validation, By Region, 2022–2029 (Usd Million)

Table 37 Artificial Intelligence In Drug Discovery Market For Hit Identification & Prioritization, By Region, 2022–2029 (Usd Million)

Table 38 Artificial Intelligence In Drug Discovery Market For Hit-to-lead Identification/Lead Generation, By Region, 2022–2029 (Usd Million)

Table 39 Artificial Intelligence In Drug Discovery Market For Lead Optimization, By Region, 2022–2029 (Usd Million)

Table 40 Artificial Intelligence In Drug Discovery Market For Candidate Selection & Validation, By Region, 2022–2029 (Usd Million)

Table 41 Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 42 Artificial Intelligence In Drug Discovery Market For Understanding Diseases, By Region, 2022–2029 (Usd Million)

Table 43 Artificial Intelligence In Drug Discovery Market For Drug Repurposing, By Region, 2022–2029 (Usd Million)

Table 44 Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 45 Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Region, 2022–2029 (Usd Million)

Table 46 Small-molecule Design Market, By Region, 2022–2029 (Usd Million)

Table 47 Vaccine Design Market, By Region, 2022–2029 (Usd Million)

Table 48 Antibody & Other Biologics Design Market, By Region,

2022–2029 (Usd Million)

Table 49 Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 50 Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Region, 2022–2029 (Usd Million)

Table 51 Small-molecule Optimization Market, By Region,

2022–2029 (Usd Million)

Table 52 Vaccine Optimization Market, By Region, 2022–2029 (Usd Million)

Table 53 Antibody & Other Biologics Optimization Market, By Region,

2022–2029 (Usd Million)

Table 54 Artificial Intelligence In Drug Discovery Market For Safety & Toxicity, By Region, 2022–2029 (Usd Million)

Table 55 Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 56 Artificial Intelligence In Drug Discovery Market For Oncology,

By Region, 2022–2029 (Usd Million)

Table 57 Artificial Intelligence In Drug Discovery Market For Infectious Diseases, By Region, 2022–2029 (Usd Million)

Table 58 Artificial Intelligence In Drug Discovery Market For Neurology,

By Region, 2022–2029 (Usd Million)

Table 59 Artificial Intelligence In Drug Discovery Market For Metabolic Diseases, By Region, 2022–2029 (Usd Million)

Table 60 Indicative List Of Developments In Cardiovascular Drug Development

Table 61 Artificial Intelligence In Drug Discovery Market For Cardiovascular Diseases, By Region, 2022–2029 (Usd Million)

Table 62 Artificial Intelligence In Drug Discovery Market For Immunology,

By Region, 2022–2029 (Usd Million)

Table 63 Artificial Intelligence In Drug Discovery Market For Mental Health Disorders, By Region, 2022–2029 (Usd Million)

Table 64 Artificial Intelligence In Drug Discovery Market For Other Therapeutic Areas, By Region, 2022–2029 (Usd Million)

Table 65 Artificial Intelligence In Drug Discovery Market, By Player Type,

2022–2029 (Usd Million)

Table 66 Artificial Intelligence In Drug Discovery Market For End-to-end Solution Providers, By Region, 2022–2029 (Usd Million)

Table 67 Artificial Intelligence In Drug Discovery Market For Niche/Point Solution Providers, By Region, 2022–2029 (Usd Million)

Table 68 Artificial Intelligence In Drug Discovery Market For Ai Technology Providers, By Region, 2022–2029 (Usd Million)

Table 69 Artificial Intelligence In Drug Discovery Market For Business Process Service Providers, By Region, 2022–2029 (Usd Million)

Table 70 Artificial Intelligence In Drug Discovery Market, By Ai Tool,

2022–2029 (Usd Million)

Table 71 Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 72 Artificial Intelligence In Drug Discovery Market For Machine Learning, By Region, 2022–2029 (Usd Million)

Table 73 Deep Learning Market, By Region, 2022–2029 (Usd Million)

Table 74 Supervised Learning Market, By Region, 2022–2029 (Usd Million)

Table 75 Reinforcement Learning Market, By Region, 2022–2029 (Usd Million)

Table 76 Unsupervised Learning Market, By Region, 2022–2029 (Usd Million)

Table 77 Other Machine Learning Technologies Market, By Region,

2022–2029 (Usd Million)

Table 78 Artificial Intelligence In Drug Discovery Market For Natural Language Processing, By Region, 2022–2029 (Usd Million)

Table 79 Artificial Intelligence In Drug Discovery Market For Context-aware Processing & Computing, By Region, 2022–2029 (Usd Million)

Table 80 Artificial Intelligence In Drug Discovery Market For Computer Vision, By Region, 2022–2029 (Usd Million)

Table 81 Artificial Intelligence In Drug Discovery Market For Image Analysis,

By Region, 2022–2029 (Usd Million)

Table 82 Artificial Intelligence In Drug Discovery Market, By Deployment,

2022–2029 (Usd Million)

Table 83 Artificial Intelligence In Drug Discovery Market For On-premises Deployment, By Region, 2022–2029 (Usd Million)

Table 84 Artificial Intelligence In Drug Discovery Market For Cloud-based Deployment, By Region, 2022–2029 (Usd Million)

Table 85 Artificial Intelligence In Drug Discovery Market For Saas-based Deployment, By Region, 2022–2029 (Usd Million)

Table 86 Artificial Intelligence In Drug Discovery Market, By End User,

2022–2029 (Usd Million)

Table 87 Indicative List Of Developments Related To Artificial Intelligence In Pharmaceutical & Biotechnology Industry

Table 88 Artificial Intelligence In Drug Discovery Market For Pharmaceutical & Biotechnology Companies, By Region, 2022–2029 (Usd Million)

Table 89 Indicative List Of Collaborations With Contract Research Organizations

Table 90 Artificial Intelligence In Drug Discovery Market For Contract Research Organizations, By Region, 2022–2029 (Usd Million)

Table 91 Indicative List Of Collaborations In Research Centers And Academic & Government Institutes

Table 92 Artificial Intelligence In Drug Discovery Market For Research Centers And Academic & Government Institutes, By Region, 2022–2029 (Usd Million)

Table 93 Artificial Intelligence In Drug Discovery Market, By Region,

2022–2029 (Usd Million)

Table 94 North America: Artificial Intelligence In Drug Discovery Market,

By Country, 2022–2029 (Usd Million)

Table 95 North America: Artificial Intelligence In Drug Discovery Market,

By Process 2022–2029 (Usd Million)

Table 96 North America: Artificial Intelligence In Drug Discovery Market,

By Use Case, 2022–2029 (Usd Million)

Table 97 North America: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 98 North America: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 99 North America: Artificial Intelligence In Drug Discovery Market,

By Therapeutic Area, 2022–2029 (Usd Million)

Table 100 North America: Artificial Intelligence In Drug Discovery Market,

By Player Type, 2022–2029 (Usd Million)

Table 101 North America: Artificial Intelligence In Drug Discovery Market,

By Ai Tool, 2022–2029 (Usd Million)

Table 102 North America: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 103 North America: Artificial Intelligence In Drug Discovery Market,

By Deployment, 2022–2029 (Usd Million)

Table 104 North America: Artificial Intelligence In Drug Discovery Market,

By End User, 2022–2029 (Usd Million)

Table 105 Us: Indicative List Of Strategic Developments

Table 106 Us: Artificial Intelligence In Drug Discovery Market, By Process

2022–2029 (Usd Million)

Table 107 Us: Artificial Intelligence In Drug Discovery Market, By Use Case,

2022–2029 (Usd Million)

Table 108 Us: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 109 Us: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 110 Us: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 111 Us: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 112 Us: Artificial Intelligence In Drug Discovery Market, By Ai Tool,

2022–2029 (Usd Million)

Table 113 Us: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 114 Us: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 115 Us: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 116 Canada: Artificial Intelligence In Drug Discovery Market, By Process 2022–2029 (Usd Million)

Table 117 Canada: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 118 Canada: Artificial Intelligence In Drug Discovery Market For

De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 119 Canada: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 120 Canada: Artificial Intelligence In Drug Discovery Market,

By Therapeutic Area, 2022–2029 (Usd Million)

Table 121 Canada: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 122 Canada: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 123 Canada: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 124 Canada: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 125 Canada: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 126 Europe: Artificial Intelligence In Drug Discovery Market, By Country 2022–2029 (Usd Million)

Table 127 Europe: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 128 Europe: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 129 Europe: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 130 Europe: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 131 Europe: Artificial Intelligence In Drug Discovery Market,

By Therapeutic Area, 2022–2029 (Usd Million)

Table 132 Europe: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 133 Europe: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 134 Europe: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 135 Europe: Artificial Intelligence In Drug Discovery Market,

By Deployment, 2022–2029 (Usd Million)

Table 136 Europe: Artificial Intelligence In Drug Discovery Market,

By End User, 2022–2029 (Usd Million)

Table 137 Uk: Indicative List Of Strategic Developments

Table 138 Uk: Artificial Intelligence In Drug Discovery Market, By Process,

2022–2029 (Usd Million)

Table 139 Uk: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 140 Uk: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 141 Uk: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 142 Uk: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 143 Uk: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 144 Uk: Artificial Intelligence In Drug Discovery Market, By Ai Tool,

2022–2029 (Usd Million)

Table 145 Uk: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 146 Uk: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 147 Uk: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 148 Germany: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 149 Germany: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 150 Germany: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 151 Germany: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 152 Germany: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 153 Germany: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 154 Germany: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 155 Germany: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 156 Germany: Artificial Intelligence In Drug Discovery Market,

By Deployment, 2022–2029 (Usd Million)

Table 157 Germany: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 158 France: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 159 France: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 160 France: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 161 France: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 162 France: Artificial Intelligence In Drug Discovery Market,

By Therapeutic Area, 2022–2029 (Usd Million)

Table 163 France: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 164 France: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 165 France: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 166 France: Artificial Intelligence In Drug Discovery Market,

By Deployment, 2022–2029 (Usd Million)

Table 167 France: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 168 Italy: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 169 Italy: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 170 Italy: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 171 Italy: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 172 Italy: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 173 Italy: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 174 Italy: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 175 Italy: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 176 Italy: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 177 Italy: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 178 Spain: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 179 Spain: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 180 Spain: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 181 Spain: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 182 Spain: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 183 Spain: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 184 Spain: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 185 Spain: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 186 Spain: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 187 Spain: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 188 Rest Of Europe: Artificial Intelligence In Drug Discovery Market,

By Process, 2022–2029 (Usd Million)

Table 189 Rest Of Europe: Artificial Intelligence In Drug Discovery Market,

By Use Case, 2022–2029 (Usd Million)

Table 190 Rest Of Europe: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 191 Rest Of Europe: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 192 Rest Of Europe: Artificial Intelligence In Drug Discovery Market,

By Therapeutic Area, 2022–2029 (Usd Million)

Table 193 Rest Of Europe: Artificial Intelligence In Drug Discovery Market,

By Player Type, 2022–2029 (Usd Million)

Table 194 Rest Of Europe: Artificial Intelligence In Drug Discovery Market,

By Ai Tool, 2022–2029 (Usd Million)

Table 195 Rest Of Europe: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 196 Rest Of Europe: Artificial Intelligence In Drug Discovery Market,

By Deployment, 2022–2029 (Usd Million)

Table 197 Rest Of Europe: Artificial Intelligence In Drug Discovery Market,

By End User, 2022–2029 (Usd Million)

Table 198 Asia Pacific: Artificial Intelligence In Drug Discovery Market,

By Country 2022–2029 (Usd Million)

Table 199 Asia Pacific: Artificial Intelligence In Drug Discovery Market,

By Process, 2022–2029 (Usd Million)

Table 200 Asia Pacific: Artificial Intelligence In Drug Discovery Market,

By Use Case, 2022–2029 (Usd Million)

Table 201 Asia Pacific: Artificial Intelligence In Drug Discovery Market

For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 202 Asia Pacific: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 203 Asia Pacific: Artificial Intelligence In Drug Discovery Market,

By Therapeutic Area, 2022–2029 (Usd Million)

Table 204 Asia Pacific: Artificial Intelligence In Drug Discovery Market,

By Player Type, 2022–2029 (Usd Million)

Table 205 Asia Pacific: Artificial Intelligence In Drug Discovery Market,

By Ai Tool, 2022–2029 (Usd Million)

Table 206 Asia Pacific: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 207 Asia Pacific: Artificial Intelligence In Drug Discovery Market,

By Deployment, 2022–2029 (Usd Million)

Table 208 Asia Pacific: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 209 Japan: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 210 Japan: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 211 Japan: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 212 Japan: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 213 Japan: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 214 Japan: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 215 Japan: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 216 Japan: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 217 Japan: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 218 Japan: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 219 China: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 220 China: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 221 China: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 222 China: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 223 China: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 224 China: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 225 China: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 226 China: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 227 China: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 228 China: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 229 India: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 230 India: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 231 India: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 232 India: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 233 India: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 234 India: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 235 India: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 236 India: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 237 India: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 238 India: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 239 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 240 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 241 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 242 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 243 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 244 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 245 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 246 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 247 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 248 Rest Of Asia Pacific: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 249 Latin America: Artificial Intelligence In Drug Discovery Market,

By Country, 2022–2029 (Usd Million)

Table 250 Latin America: Artificial Intelligence In Drug Discovery Market,

By Process, 2022–2029 (Usd Million)

Table 251 Latin America: Artificial Intelligence In Drug Discovery Market,

By Use Case, 2022–2029 (Usd Million)

Table 252 Latin America: Artificial Intelligence In Drug Discovery Market

For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 253 Latin America: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 254 Latin America: Artificial Intelligence In Drug Discovery Market,

By Therapeutic Area, 2022–2029 (Usd Million)

Table 255 Latin America: Artificial Intelligence In Drug Discovery Market,

By Player Type, 2022–2029 (Usd Million)

Table 256 Latin America: Artificial Intelligence In Drug Discovery Market,

By Ai Tool, 2022–2029 (Usd Million)

Table 257 Latin America: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 258 Latin America: Artificial Intelligence In Drug Discovery Market,

By Deployment, 2022–2029 (Usd Million)

Table 259 Latin America: Artificial Intelligence In Drug Discovery Market,

By End User, 2022–2029 (Usd Million)

Table 260 Brazil: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 261 Brazil: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 262 Brazil: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 263 Brazil: Artificial Intelligence In Drug Discovery Market For Drug Discovery, By Type, 2022–2029 (Usd Million)

Table 264 Brazil: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 265 Brazil: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 266 Brazil: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 267 Brazil: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 268 Brazil: Artificial Intelligence In Drug Discovery Market,

By Deployment, 2022–2029 (Usd Million)

Table 269 Brazil: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 270 Mexico: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 271 Mexico: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 272 Mexico: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 273 Mexico: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 274 Mexico: Artificial Intelligence In Drug Discovery Market,

By Therapeutic Area, 2022–2029 (Usd Million)

Table 275 Mexico: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 276 Mexico: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 277 Mexico: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 278 Mexico: Artificial Intelligence In Drug Discovery Market,

By Deployment, 2022–2029 (Usd Million)

Table 279 Me xico: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 280 Rest Of Latin America: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 281 Rest Of Latin America: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 282 Rest Of Latin America: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 283 Rest Of Latin America: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 284 Rest Of Latin America: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 285 Rest Of Latin America: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 286 Rest Of Latin America: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 287 Rest Of Latin America: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 288 Rest Of Latin America: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 289 Rest Of Latin America: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 290 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Region, 2022–2029 (Usd Million)

Table 291 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 292 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 293 Middle East & Africa: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 294 Middle East & Africa: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 295 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 296 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 297 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 298 Middle East & Africa: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 299 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 300 Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 301 Gcc Countries: Artificial Intelligence In Drug Discovery Market,

By Process, 2022–2029 (Usd Million)

Table 302 Gcc Countries: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 303 Gcc Countries: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 304 Gcc Countries: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 305 Gcc Countries: Artificial Intelligence In Drug Discovery Market,

By Therapeutic Area, 2022–2029 (Usd Million)

Table 306 Gcc Countries: Artificial Intelligence In Drug Discovery Market,

By Player Type, 2022–2029 (Usd Million)

Table 307 Gcc Countries: Artificial Intelligence In Drug Discovery Market,

By Ai Tool, 2022–2029 (Usd Million)

Table 308 Gcc Countries: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 309 Gcc Countries: Artificial Intelligence In Drug Discovery Market,

By Deployment, 2022–2029 (Usd Million)

Table 310 Gcc Countries: Artificial Intelligence In Drug Discovery Market,

By End User, 2022–2029 (Usd Million)

Table 311 Rest Of Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Process, 2022–2029 (Usd Million)

Table 312 Rest Of Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Use Case, 2022–2029 (Usd Million)

Table 313 Rest Of Middle East & Africa: Artificial Intelligence In Drug Discovery Market For De Novo Drug Design, By Type, 2022–2029 (Usd Million)

Table 314 Rest Of Middle East & Africa: Artificial Intelligence In Drug Discovery Market For Drug Optimization, By Type, 2022–2029 (Usd Million)

Table 315 Rest Of Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2022–2029 (Usd Million)

Table 316 Rest Of Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Player Type, 2022–2029 (Usd Million)

Table 317 Rest Of Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Ai Tool, 2022–2029 (Usd Million)

Table 318 Rest Of Middle East & Africa: Artificial Intelligence In Drug Discovery Market For Machine Learning, By Type, 2022–2029 (Usd Million)

Table 319 Rest Of Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By Deployment, 2022–2029 (Usd Million)

Table 320 Rest Of Middle East & Africa: Artificial Intelligence In Drug Discovery Market, By End User, 2022–2029 (Usd Million)

Table 321 Overview Of Strategies Adopted By Key Players In Artificial Intelligence In Drug Discovery Market, January 2021–october 2024

Table 322 Artificial Intelligence In Drug Discovery Market: Degree Of Competition

Table 323 Artificial Intelligence In Drug Discovery Market: Use Case Footprint

Table 324 Artificial Intelligence In Drug Discovery Market: Process Footprint

Table 325 Artificial Intelligence In Drug Discovery Market: Therapeutic Area Footprint

Table 326 Artificial Intelligence In Drug Discovery Market: Player Type Footprint

Table 327 Artificial Intelligence In Drug Discovery Market: Deployment Mode Footprint

Table 328 Artificial Intelligence In Drug Discovery Market: Region Footprint

Table 329 Artificial Intelligence In Drug Discovery Market: Detailed List Of Key Startup/Sme Players

Table 330 Artificial Intelligence In Drug Development Market: Competitive Benchmarking Of Key Emerging Players/Startups, By Region

Table 331 Artificial Intelligence In Drug Discovery Market: Product And Solution Launches, January 2021–october 2024

Table 332 Artificial Intelligence In Drug Discovery Market: Deals,

January 2021–october 2024

Table 333 Artificial Intelligence In Drug Discovery Market: Expansions, January 2021–october 2024

Table 334 Artificial Intelligence In Drug Discovery Market: Other Developments, January 2021–october 2024

Table 335 Nvidia Corporation: Company Overview

Table 336 Nvidia Corporation: Products/Services/Solutions Offered

Table 337 Nvidia Corporation: Product And Service Launches,

January 2021–october 2024

Table 338 Nvidia Corporation: Deals, January 2021–october 2024

Table 339 Exscientia: Company Overview

Table 340 Exscientia: Products/Services/Solutions Offered

Table 341 Exscientia: Solution Launches, January 2021–october 2024

Table 342 Exscientia: Deals, January 2021–october 2024

Table 343 Exscientia: Expansions, January 2021–october 2024

Table 344 Exscientia: Other Developments, January 2021–october 2024

Table 345 Google: Company Overview

Table 346 Google: Products/Services/Solutions Offered

Table 347 Google: Solution Launches, January 2021–october 2024

Table 348 Google: Deals, January 2021–october 2024

Table 349 Google: Expansions, January 2021–october 2024

Table 350 Recursion: Company Overview

Table 351 Recursion: Products/Services/Solutions Offered

Table 352 Recursion: Solution Launches, January 2021–october 2024

Table 353 Recursion: Deals, January 2021–october 2024

Table 354 Recursion: Expansions, January 2021–october 2024

Table 355 Insilico Medicine: Company Overview

Table 356 Insilico Medicine: Products/Services/Solutions Offered

Table 357 Insilico Medicine: Product And Solution Launches And Developments, January 2021–october 2024

Table 358 Insilico Medicine: Deals, January 2021–october 2024

Table 359 Insilico Medicine: Other Developments, January 2021–october 2024

Table 360 Schrödinger, Inc.: Company Overview

Table 361 Schrödinger, Inc.: Products/Services/Solutions Offered

Table 362 Schrödinger, Inc.: Deals, January 2021–october 2024

Table 363 Schrödinger, Inc.: Other Developments, January 2021–october 2024

Table 364 Benevolentai: Company Overview

Table 365 Benevolentai: Products/Services/Solutions Offered

Table 366 Benevolentai: Deals, January 2021–october 2024

Table 367 Microsoft Corporation: Company Overview

Table 368 Microsoft Corporation: Products/Services/Solutions Offered

Table 369 Microsoft Corporation: Deals, January 2021–october 2024

Table 370 Atomwise Inc.: Company Overview

Table 371 Atomwise Inc.: Products/Services/Solutions Offered

Table 372 Atomwise Inc.: Deals, January 2021–october 2024

Table 373 Illumina, Inc.: Company Overview

Table 374 Illumina, Inc.: Products/Services/Solutions Offered

Table 375 Illumina, Inc.: Solution Launches, January 2021–october 2024

Table 376 Illumina, Inc.: Deals, January 2021–october 2024

Table 377 Numedii, Inc.: Company Overview

Table 378 Numedii, Inc.: Products/Services/Solutions Offered

Table 379 Xtalpi Inc.: Company Overview

Table 380 Xtalpi Inc.: Products/Services/Solutions Offered

Table 381 Xtalpi Inc.: Deals, January 2021–october 2024

Table 382 Iktos: Company Overview

Table 383 Iktos: Products/Services/Solutions Offered

Table 384 Iktos: Deals, January 2021–october 2024

Table 385 Iktos: Other Developments, January 2021–october 2024

Table 386 Tempus: Company Overview

Table 387 Tempus: Products/Services/Solutions Offered

Table 388 Tempus: Solution Launches, January 2021–october 2024

Table 389 Tempus: Deals, January 2021–october 2024

Table 390 Tempus: Expansions, January 2021–october 2024

Table 391 Tempus: Other Developments, January 2021–october 2024

Table 392 Deep Genomics: Company Overview

Table 393 Deep Genomics: Products/Services/Solutions Offered

Table 394 Deep Genomics: Solution Launches, January 2021–october 2024

Table 395 Deep Genomics: Deals, January 2021–october 2024

Table 396 Deep Genomics: Other Developments, January 2021–october 2024

Table 397 Verge Genomics: Company Overview

Table 398 Verge Genomics: Products/Services/Solutions Offered

Table 399 Verge Genomics: Deals, January 2021–october 2024

Table 400 Benchsci: Company Overview

Table 401 Benchsci: Products/Services/Solutions Offered

Table 402 Benchsci: Solution Launches, January 2021–october 2024

Table 403 Benchsci: Deals, January 2021–october 2024

Table 404 Benchsci: Other Developments, January 2021–october 2024

Table 405 Insitro: Company Overview

Table 406 Insitro: Products/Services/Solutions Offered

Table 407 Insitro: Deals, January 2021–october 2024

Table 408 Insitro: Other Developments, January 2021–october 2024

Table 409 Valo Health: Company Overview

Table 410 Valo Health: Products/Services/Solutions Offered

Table 411 Valo Health: Deals, January 2021–october 2024

Table 412 Valo Health: Other Developments, January 2021–october 2024

Table 413 Bpgbio, Inc.: Company Overview

Table 414 Bpgbio, Inc.: Products/Services/Solutions Offered

Table 415 Bpgbio, Inc.: Deals, January 2021–october 2024

Table 416 Merck Kgaa: Company Overview

Table 417 Merck Kgaa: Products/Services/Solutions Offered

Table 418 Merck Kgaa: Solution Launches, January 2021–october 2024

Table 419 Merck Kgaa: Deals, January 2021–october 2024

Table 420 Merck Kgaa: Expansions, January 2021–october 2024

Table 421 Merck Kgaa: Other Developments, January 2021–october 2024

Table 422 Predictive Oncology: Company Overview

Table 423 Iqvia Inc.: Company Overview

Table 424 Tencent Holdings Limited: Company Overview

Table 425 Cytoreason Ltd.: Company Overview

Table 426 Owkin, Inc.: Company Overview

Table 427 Cloud Pharmaceuticals: Company Overview

Table 428 Evaxion Biotech A/S: Company Overview

Table 429 Standigm Inc.: Company Overview

Table 430 Bioage Labs: Company Overview

Table 431 Envisagenics: Company Overview

Table 432 Abcellera: Company Overview

Table 433 Centella: Company Overview

Figures List

Figure 1 Artificial Intelligence In Drug Discovery Market: Segments And Regions Considered

Figure 2 Artificial Intelligence In Drug Discovery Market: Years Considered

Figure 3 Artificial Intelligence In Drug Discovery Market: Research Design

Figure 4 Artificial Intelligence In Drug Discovery Market:

Key Data From Secondary Sources

Figure 5 Artificial Intelligence In Drug Discovery Market: Key Primary Sources

Figure 6 Artificial Intelligence In Drug Discovery Market:

Key Data From Primary Sources

Figure 7 Artificial Intelligence In Drug Discovery Market: Key Industry Insights

Figure 8 Breakdown Of Primary Interviews: By Demand Side, Supply Side, Designation, And Region

Figure 9 Research Methodology: Hypothesis Building

Figure 10 Supply-side Market Estimation: Revenue Share Analysis

Figure 11 Artificial Intelligence In Drug Discovery Market: Revenue Share Analysis Illustration

Figure 12 Bottom-up Approach: End-user Spending On Artificial Intelligence In Drug Discovery

Figure 13 Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges (2024–2029)

Figure 14 Cagr Projections: Supply-side Analysis

Figure 15 Artificial Intelligence In Drug Discovery Market: Top-down Approach

Figure 16 Artificial Intelligence In Drug Discovery Market: Data Triangulation

Figure 17 Artificial Intelligence In Drug Discovery Market, By Process,

2024 Vs. 2029 (Usd Million)

Figure 18 Artificial Intelligence In Drug Discovery Market, By Use Case,

2024 Vs. 2029 (Usd Million)

Figure 19 Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2024 Vs. 2029 (Usd Million)

Figure 20 Artificial Intelligence In Drug Discovery Market, By Player Type,

2024 Vs. 2029 (Usd Million)

Figure 21 Artificial Intelligence In Drug Discovery Market, By Ai Tool,

2024 Vs. 2029 (Usd Million)

Figure 22 Artificial Intelligence In Drug Discovery Market, By Deployment,

2024 Vs. 2029 (Usd Million)

Figure 23 Artificial Intelligence In Drug Discovery Market, By End User,

2024 Vs. 2029 (Usd Million)

Figure 24 Artificial Intelligence In Drug Discovery Market: Regional Snapshot

Figure 25 Increasing Number Of Cross-industry Collaborations And Partnerships To Drive Market

Figure 26 Us And Pharmaceutical & Biotechnology Companies Commanded Largest Market Share In 2023

Figure 27 India To Register Highest Growth Rate From 2024 To 2029

Figure 28 North America To Dominate Market During Forecast Period

Figure 29 Emerging Markets To Register Higher Growth Rates During Study Period

Figure 30 Artificial Intelligence In Drug Discovery Market: Drivers, Restraints, Opportunities, And Challenges

Figure 31 Cost Of Genome Analysis Vs. Levels Of Raw Data Generated, 2003–2023

Figure 32 Approval Of Personalized Medicines By Us Fda, 2015–2023

Figure 33 Artificial Intelligence In Drug Discovery Market: Trends/Disruptions Impacting Customer’s Business

Figure 34 Evolution Of Ai In Drug Discovery Market

Figure 35 Artificial Intelligence In Drug Discovery Market: Structure-based Drug Designing

Figure 36 Artificial Intelligence In Drug Discovery Market: Ecosystem Analysis

Figure 37 Artificial Intelligence In Drug Discovery Market: Supply Chain Analysis

Figure 38 Artificial Intelligence In Drug Discovery Market: Types Of Service

Figure 39 Artificial Intelligence In Drug Discovery Market: Porter’s Five Forces Analysis

Figure 40 Influence Of Stakeholders On Buying Process For End Users

Figure 41 Key Buying Criteria For Top Three End Users

Figure 42 Jurisdiction Analysis: Top Applicant Countries For “ai In Drug Discovery” Patents (January 2015–september 2024)

Figure 43 Major Patents In Artificial Intelligence In Drug Discovery Market (January 2015–september 2024)

Figure 44 Artificial Intelligence In Drug Discovery Market: Business Models

Figure 45 Benefits Of Hybrid Business Models

Figure 46 Specialization Of Artificial Intelligence-based Companies Over Time

Figure 47 Funding In Artificial Intelligence In Drug Discovery Market,

2013–2022 (Usd Million)

Figure 48 Market Potential Of Ai/Generative Ai In Enhancing Laboratory Informatics Across Industries

Figure 49 Impact Of Ai/Generative Ai On Interconnected And Adjacent Ecosystems

Figure 50 Hit-to-lead Identification/Lead Generation Segment Held Largest Market Share In 2023

Figure 51 North America: Artificial Intelligence In Drug Discovery Market Snapshot

Figure 52 Distribution Of R&D Companies, By Country/Region (2022 Vs. 2023)

Figure 53 Asia Pacific: Artificial Intelligence In Drug Discovery Market Snapshot

Figure 54 Revenue Analysis Of Key Players In Artificial Intelligence In Drug Discovery Market (2019–2023)

Figure 55 Market Share Analysis Of Key Players In Artificial Intelligence In Drug Discovery Market (2023)

Figure 56 Artificial Intelligence In Drug Discovery Market: Ranking Of Key Market Players (2023)

Figure 57 Artificial Intelligence In Drug Discovery Market: Company Evaluation Matrix (Key Players), 2023

Figure 58 Artificial Intelligence In Drug Discovery Market: Company Footprint

Figure 59 Artificial Intelligence In Drug Discovery Market: Company Evaluation Matrix (Startups/Smes), 2023

Figure 60 Ev/Ebitda Of Key Vendors

Figure 61 Year-to-date (Ytd) Price Total Return And 5-year Stock

Beta Of Key Vendors

Figure 62 Artificial Intelligence In Drug Discovery Market:

Brand/Product Comparative Analysis

Figure 63 Nvidia Corporation: Company Snapshot

Figure 64 Exscientia: Company Snapshot

Figure 65 Google: Company Snapshot

Figure 66 Recursion: Company Snapshot

Figure 67 Schrödinger, Inc.: Company Snapshot

Figure 68 Benevolentai: Company Snapshot

Figure 69 Microsoft Corporation: Company Snapshot

Figure 70 Illumina, Inc.: Company Snapshot

Figure 71 Merck Kgaa: Company Snapshot